These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6640930)
1. Long-term and short-term histopathologic changes in the skin after PUVA therapy. Ingraham DM; Bergfeld WF; Bailin PL; Steck WD; Taylor JS; Tomecki KJ Cleve Clin Q; 1983; 50(2):133-9. PubMed ID: 6640930 [No Abstract] [Full Text] [Related]
2. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients. Levin DL; Roenigk HH; Caro WA; Lyons M J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505 [TBL] [Abstract][Full Text] [Related]
3. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study. Abel EA; Cox AJ; Farber EM J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Berne B; Fischer T; Michaëlsson G; Norén P Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278 [TBL] [Abstract][Full Text] [Related]
5. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions. Ros AM; Wennersten G; Lagerholm B Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634 [TBL] [Abstract][Full Text] [Related]
6. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA). Hönigsmann H; Wolff K; Gschnait F; Brenner W; Jaschke E J Am Acad Dermatol; 1980 Oct; 3(4):406-14. PubMed ID: 7430462 [No Abstract] [Full Text] [Related]
7. Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis. Hazen PG; Carney JF; Walker AE; Stewart JJ; Engstrom CW J Am Acad Dermatol; 1985 Jun; 12(6):1077-8. PubMed ID: 4008702 [TBL] [Abstract][Full Text] [Related]
8. Hyperpigmentation and hypopigmentation of the skin after long term PUVA therapy. Light and electron microscopic observations on three patients. Kanerva L; Niemi KM; Lassus A J Cutan Pathol; 1981 Jun; 8(3):199-213. PubMed ID: 7309935 [TBL] [Abstract][Full Text] [Related]
14. Risk of skin tumors in psoralen- and ultraviolet A-treated patients. Henseler T; Christophers E Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033 [TBL] [Abstract][Full Text] [Related]
15. The relationship of skin cancer to PUVA therapy in Australia. Lobel E; Paver K; King R; Le Guay J; Poyzer K; Wargon O Australas J Dermatol; 1981 Dec; 22(3):100-3. PubMed ID: 7344686 [No Abstract] [Full Text] [Related]
16. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy. Frenk E Dermatologica; 1983; 167(3):152-4. PubMed ID: 6414855 [No Abstract] [Full Text] [Related]
17. Cutaneous carcinoma in psoriatic patients treated with PUVA. Reshad H; Challoner F; Pollock DJ; Baker H Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845 [TBL] [Abstract][Full Text] [Related]
18. Synergistic carcinogenic potential of methotrexate and PUVA in psoriasis. Fitzsimons CP; Long J; MacKie RM Lancet; 1983 Jan; 1(8318):235-6. PubMed ID: 6130262 [No Abstract] [Full Text] [Related]
19. [Changes in the loci minoris resistentiae of the dermis in photosclerosis]. Pierard GE; Pierard-Franchimont C; Lapière CM Dermatologica; 1983; 167(3):121-6. PubMed ID: 6628808 [TBL] [Abstract][Full Text] [Related]